Drug Search Results
More Filters [+]

Cefdinir

Alternative Names: cefdinir, omnicef
Latest Update: 2024-06-28
Latest Update Note: Clinical Trial Update

Product Description

Cefdinir is used to treat certain infections caused by bacteria such as bronchitis (infection of the airway tubes leading to the lungs); pneumonia; and infections of the skin, ears, sinuses, throat, and tonsils.. Cefdinir is in a class of medications called cephalosporin antibiotics. It works by killing bacteria. (Sourced from: https://medlineplus.gov/druginfo/meds/a698001.html)

Mechanisms of Action: Cell Wall Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Bangladesh | Chile | Colombia | Ecuador | Egypt | India | Indonesia | Ireland | Jordan | Korea | Lebanon | Mexico | Pakistan | Peru | Philippines | Portugal | Saudi Arabia | Sweden | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United States | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Abbott Laboratories
Company Location: ABBOTT PARK IL 60064-3500
Company CEO: Robert B. Ford
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cefdinir

Countries in Clinic: China

Active Clinical Trial Count: 5

Highest Development Phases

Phase 1: Abscess|Anthrax|Blepharitis|Bronchitis, Chronic|Carbuncle|Cellulitis|Cystitis|Erysipelas|Escherichia coli Infections|Folliculitis|Haemophilus Infections|Hidradenitis|Inflammation|Influenza, Human|Klebsiella Infections|Laryngitis|Lymphadenitis|Lymphangitis|Mastitis|Otitis Media|Otitis Media, Suppurative|Paronychia|Pharyngitis|Pneumonia|Pneumonia, Bacterial|Proteus Infections|Pyelonephritis|Pyoderma|Scarlet Fever|Sinusitis|Surgical Wound Infection|Tonsillitis|Urethritis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20211160

P1

Not yet recruiting

Pyelonephritis|Pyoderma|Cystitis|Klebsiella Infections|Otitis Media, Suppurative|Escherichia coli Infections|Abscess|Proteus Infections|Pharyngitis|Influenza, Human|Cellulitis|Hidradenitis|Lymphangitis|Bronchitis, Chronic|Carbuncle|Inflammation|Folliculitis|Scarlet Fever|Erysipelas|Anthrax|Paronychia|Pneumonia|Sinusitis|Haemophilus Infections

None

CTR20132519

P1

Recruiting

Pharyngitis|Pyoderma|Proteus Infections|Erysipelas|Tonsillitis|Urethritis|Lymphadenitis|Carbuncle|Sinusitis|Haemophilus Infections|Blepharitis|Abscess|Surgical Wound Infection|Paronychia|Pneumonia|Klebsiella Infections|Folliculitis|Pyelonephritis|Influenza, Human|Escherichia coli Infections|Cellulitis|Otitis Media|Cystitis|Bronchitis, Chronic|Mastitis

None

CTR20202701

P1

Not yet recruiting

Bronchitis, Chronic|Laryngitis|Proteus Infections|Pneumonia, Bacterial|Pyoderma|Influenza, Human|Tonsillitis|Lymphadenitis|Pharyngitis|Otitis Media|Pyelonephritis|Escherichia coli Infections|Scarlet Fever|Sinusitis|Cystitis|Klebsiella Infections|Haemophilus Infections

None

CTR20130963

P1

Active, not recruiting

Otitis Media, Suppurative|Pyelonephritis|Folliculitis|Mastitis|Sinusitis|Hidradenitis|Cellulitis|Cystitis|Carbuncle|Klebsiella Infections|Paronychia|Pyoderma|Pneumonia|Proteus Infections|Pharyngitis|Bronchitis, Chronic|Lymphangitis|Abscess|Influenza, Human|Anthrax|Blepharitis|Urethritis|Erysipelas|Escherichia coli Infections|Tonsillitis

None

Recent News Events